PAGE 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITES EXCHANCE ACT OF 1934
(Amendment No._____)*
Nutraceutix, Inc.
- ------------------------------------------------------------
------------
(Name of Issuer)
Common Stock, $.001 Par Value
- ------------------------------------------------------------
------------
(Title of Class of Securities)
67060V107
- ------------------------------------------------------------
------------
(CUSIP Number)
6/30/99
- ------------------------------------------------------------
------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this
Schedule is filed
[ ] Rule 13d-1 (b)
[X] Rule 13d-1 (c)
[ ] Rule 13d-1 (d)
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
1
PAGE 2
CUSIP NO. 67060V107 Page 2 of 5 Pages
(1) NAME OF REPORTING PERSONS/
I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSONS
(ENTITIES ONLY)
Archer-Daniels-Midland Company/041-012-9150
-------------------------------------------------------
- --------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF GROUP*
(a) [ ]
(b) [ ]
-------------------------------------------------------
- --------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------
- --------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATON
Delaware, United States of America
-------------------------------------------------------
- --------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
SHARES 1,920,000
BENEFICIALLY -----------------------------------
- ------------------------
OWNED BY (6) SHARED VOTING POWER
EACH -0-
REPORTING -----------------------------------
- ------------------------
PERSON WITH (7) SOLE DISPOSITIVE POWER
1,920,000
-----------------------------------
- -------------------------
(8) SHARED DISPOSITIVE POWER
-0-
-----------------------------------
- --------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,920,000
-------------------------------------------------------
- --------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------
- --------------------------------------------
2
PAGE 3
CUSIP NO. 67060V107 Page 3 of 5
Pages
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.9% (Based on information as to shares outstanding
shown in the 1999 proxy
statement)
-------------------------------------------------------
- --------------------------------------------
(12) TYPE OF REPORTING PERSON*
CO
-------------------------------------------------------
- --------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Item 1(a). Name of Issuer:
(a) Nutraceutix, Inc.
Item 1 (b). Address of Issuer's Principal Executive
Offices:
(b) 8340 154th Avenue N.E., Redmond, Washington 98052
Item 2(a). Name of Person Filing:
(a) Archer-Daniels-Midland Company
Item 2(b). Address of Principal Business Offices or, if
None, Residence:
(b) 4666 Faries Parkway, Decatur, IL 62526
Item 2(c). Citizenship:
(c) Delaware, U.S.A.
Item 2 (d). Title of Class of Securities:
(d) Common Stock, $.001 Par Value
Item 2 (e). CUSIP Number:
(e) CUSIP # 67060V107
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d -
1(b) OR 13d- 2(b) OR (c), CHECK WHETHER THE PERSON
FILING IS A:
Not Applicable
ITEM 4. OWNERSHIP:
Item 4(a). Amount Beneficially Owned:
(a) 1,920,000
3
PAGE 4
CUSIP NO. 67060V107 Page 4 of 5 Pages
Item 4 (b). Percent of Class:
(b) 10.9% (Based on information as to shares
outstanding shown in the 1999
proxy statement.)
Item 4 (c). Number of Shares as to which such person has:
Item 4(c)(i). Sole power to vote or to direct the vote
(i) 1,920,000 shares
Item 4(c)(ii). Shared power to vote or to direct the vote
(ii) -0- shares
Item 4(c)(iii). Sole power to dispose or to direct the
disposition of
(iii) 1,920,000 shares
Item 4(c)(iv). Shared power to dispose or to direct the
disposition of
(iv) -0- shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not Applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON:
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE
SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING
REPORTED ON BY
THE PARENT HOLDING COMPANY:
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF
THE
GROUP:
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not Applicable
4
PAGE 5
CUSIP NO. 67060V107 Page 5 of 5
Pages
ITEM 10. CERTIFICATION :
"By signing below I certify that, to the best of
my knowledge and belief, the securities referred to
above were not acquired and are not held for the
purpose of or with the effect of changing or
influencing the control of the issuer of the securities
and were not acquired and are not held in connection
with or as a participant in any transaction having that
purpose or effect."
SIGNATURES
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.
February 11, 2000
Date
/s/ D. J. Smith
Vice President, Secretary
and General Counsel
5
